GAMMA Investing’s Definium Therapeutics DFTX Stock Holding History

GAMMA Investing’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$59.2K	Buy	1,555 +343	+28%	+$14.5K	﹤0.01%	2258
2026 Q2	$57K	Buy	1,212 +101	+9%	+$2.5K	﹤0.01%	2217
2026 Q1	$21K	Buy	1,111 +81	+8%	+$1.38K	﹤0.01%	2689
2025 Q4	$13.8K	Buy	1,030 +111	+12%	+$1.37K	﹤0.01%	2819
2025 Q3	$10.8K	Sell	919 -189	-17%	-$1.76K	﹤0.01%	2843
2025 Q2	$7.19K	Buy	1,108 +415	+60%	+$2.73K	﹤0.01%	2970
2025 Q1	$4.05K	Buy	693 +587	+554%	+$4.2K	﹤0.01%	3166
2024 Q4	$738	Sell	106 -77	-42%	-$530	﹤0.01%	3504
2024 Q3	$1.04K	Buy	+183	New	+$1.27K	﹤0.01%	3243

Other funds holding DFTX

SCI

Stableford Capital II Scottsdale, Arizona $288M AUM 21.3% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

BWM

Bullock Wealth Management Bloomington, Indiana $241M AUM 23.31% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing's DFTX Position: Q3 2026 in Review

GAMMA Investing increased its Definium Therapeutics (DFTX) stake by 28% in Q3 2026, buying an estimated $14.5K and bringing the position to 1,555 shares worth $59.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

GAMMA Investing first reported a position in DFTX in Q3 2024 and has held it in 9 quarters since. 8 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

GAMMA Investing held 1,555 shares of Definium Therapeutics worth $59.2K as of Q3 2026.
GAMMA Investing bought 343 Definium Therapeutics shares in Q3 2026, an estimated $14.5K.
Definium Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2258 holding.
GAMMA Investing first reported a position in Definium Therapeutics in Q3 2024 and has held it in 9 quarters since.
8 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.